Definitive Contract HHSN261200800025C

<p>This is a $299,813 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Hylapharm LLC, a self-certified small disadvantaged business, under the SBIR Program Phase I. The contract is for the development of &quot;Targeted Nanoparticle Treatment for Breast Cancer Stem Cells.&quot; This contract has a Total Small Business set-aside designation. The contract has an ultimate completion date of September 17, 2016.</p>

This federal contract award was made by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to HS Design, Inc. (doing business as HSD), a product development and medical design firm. The $289,443.00 award is for the development of a novel dosing and dispensing system for multiparticulate cancer drugs under the Small Business Innovation Research (SBIR) program. The period of performance is from September 21, 2017 through June 20, 2018,...

<p>The U.S. Department of Health and Human Services (HHS) awarded a $149,935 firm-fixed-price Small Business Innovation Research (SBIR) Phase I contract to Quantum Mark, LLC, a woman-owned small disadvantaged business. The contract, awarded on September 30, 2007, is for the development of an automated system to process cancer-related data, under SBIR Topic 233. The contract has a period of performance through May 30, 2008 and was set aside for small businesses.</p>

This is a federal contract award from the U.S. Department of Health and Human Services (HHS) to Interactive Performance Technologies LLC, a small business contractor. The contract is for a Small Business Innovation Research (SBIR) Phase I project titled &quot;Integrating Patient-Reported Outcomes in Hospice and Palliative Care Practices,&quot; with a ceiling value of $160,798.00. The contract has a firm fixed-price pricing type and a period of performance ending on June 30, 2009. The place of...

This is a $199,892.00 federal contract awarded by the National Cancer Institute, a civilian agency, to Eutropics Pharmaceuticals, a for-profit small business. The contract is for basic research and development in the &quot;OTHER FUNCTIONS R &amp; D- BIOMEDICAL (BASIC RESEARCH)&quot; domain as part of the SBIR Program Phase I. The contract is a definitive, firm fixed-price agreement with a completion date of June 21, 2013. This contract award has a total small business set-aside designation.

This is a Small Business Innovation Research (SBIR) Program Phase I contract awarded by the Department of Health and Human Services (HHS) to Nanocomposix, Inc., a small business manufacturer of engineered nanoparticles, for the development of &quot;small hollow nanodelivery vehicles for cancer treatment.&quot; The fixed-price contract has a ceiling value of $200,000.00 and a period of performance ending on March 30, 2010. Nanocomposix has previously performed prime contracts and subcontracts for...

This is a $289,828.00 SBIR Phase I contract awarded by the Department of Health and Human Services' National Institutes of Health National Cancer Institute to Nicolalde R&amp;D LLC, a minority-owned, self-certified small disadvantaged business. The contract is a firm fixed-price definitive contract with a completion date of November 30, 2021. The SBIR (Small Business Innovation Research) Program Phase I award indicates this contract is for early-stage research and development activities. As a...

This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian agency, to Detroit R&amp;D, Inc., a minority-owned, economically disadvantaged, woman-owned small business. The contract is for R&amp;D in biomedical basic research with a ceiling value of $299,097. The contract is a definitive, firm-fixed-price contract with a period of performance ending on September 21, 2016. This SBIR Phase I award will support the development of...

This is a $355,000.00 Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Immunotarget Therapeutics Inc., a woman-owned small business. The contract is for the NCI's Small Business Innovation Research (SBIR) Innovative Concept Award program, which seeks proposals for highly innovative therapies, diagnostic tools, or preventive strategies focused on pediatric and/or rare cancers. The...

The federal contract award HHSN261200700013C, valued at $749,438.00, was issued by the National Cancer Institute (NCI), a civilian agency, to Scientific Software International, Inc. (SSI) under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of an Outcomes Research System called &quot;OTHER FUNCTIONS MEDPRO&quot; and is a Definitive Contract with a Cost Plus Fixed Fee pricing type. The contract has a total small business set-aside designation...